Clinical Trials Logo

Clinical Trial Summary

The study is a multicenter, retrospective and prospective, non-randomized, non-controlled and consecutive series post-market study. The purpose of this study is to collect long-term data confirming safety, performance and clinical benefits of the Anatomical Shoulder 2.0 Fracture System (Implants and Instrumentation) when used for fracture shoulder arthroplasty. The primary objective is the assessment of safety by analyzing implant survivorship. This will be established by recording the incidence and frequency of revisions, complications and adverse events. Relation of the events to implant, instrumentation and/or procedure should be specified. The secondary objective is the assessment of performance and clinical benefits by recording patient-reported clinical outcome measures (PROMs) as well as radiographic outcomes.


Clinical Trial Description

The Anatomical Shoulder 2.0 Fracture System is intended for use in prosthetic replacement of the proximal humerus and the glenoid articular surface of the scapula during total, hemi and fracture shoulder arthroplasty. The system is intended for long-term implantation into the human shoulder joint to relieve pain and restore function in patients with adequate bone stock to support the prosthesis. Two sites will be involved in this study. The aim is to include a total of 78 consecutive series cases who received the Anatomical Shoulder 2.0 Fracture starting from 2014. All potential study subjects will be required to participate in the Informed Consent Process. Baseline data from the preop, intraop and immediate post-op intervals will be available in medical notes and collected retrospectively. During follow-up visits at 1, 3, 5, 7 and 10 years post-op (depending on patients' date of surgery), the patient will be asked to complete patient questionnaires. Moreover, a clinical assessment and a radiographic evaluation will be conducted. In addition, any complications and adverse events will also be collected during these follow-up visits. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05351112
Study type Observational
Source Zimmer Biomet
Contact Julie Nicoux
Phone +33 06 72 61 35 02
Email julie.nicoux@zimmerbiomet.com
Status Recruiting
Phase
Start date July 7, 2022
Completion date January 21, 2034

See also
  Status Clinical Trial Phase
Terminated NCT02362100 - Proximal Humerus Fractures Randomized Control Trial N/A
Recruiting NCT04106674 - Two- Part Proximal Humerus - Conservative vs Operative N/A
Recruiting NCT05943574 - PMCF Study on the Safety, Performance and Clinical Benefits Data of the XtraFix® Small External Fixation System
Recruiting NCT03060876 - Hanover Humerus Registry N/A
Completed NCT03646253 - Analysis of Four-fragment Fractures of the Proximal Humerus: the Interest of 2D and 3D Imagery and Inter- and Intra-observer Reproducibility
Not yet recruiting NCT04572022 - Impact of Mobile Health Technology Application on Proximal Humerus Fracture Care Practice N/A
Active, not recruiting NCT05952622 - Outcome After Plate Osteosynthesis of Proximal Humerus Fractures Using Continous Passive Motioning Therapy N/A